ACRX - AcelRx Pharmaceuticals GAAP EPS of -$0.06 beats by $0.01 revenue of $0.2M misses by $1.65M March, 10 2022 04:08 PM AcelRx Pharmaceuticals Inc. AcelRx Pharmaceuticals press release (NASDAQ:ACRX): Q4 GAAP EPS of -$0.06 beats by $0.01. Revenue of $0.2M (-73.0% Y/Y) misses by $1.65M. For further details see: AcelRx Pharmaceuticals GAAP EPS of -$0.06 beats by $0.01, revenue of $0.2M misses by $1.65M